OTC Tip Reporter

OTC Tip Reporter

Top Emerging Growth Companies
https://www.otctipreporter.com/

Gilead and Galapagos' filgotinib OK'd in Europe

OTC Tip Reporter
OTC Tip Reporter 9/25/2020 5:25:00 PM

Investor Relations for NASDAQ and NYSE Public Companies Call OTC Tip Reporter 800-850-9305

Gilead and Galapagos' filgotinib OK'd in Europe for rheumatoid arthritis (NASDAQ:GILD)

Looking for additional coverage on your company? Businesses trading on the NASDAQ or New York Stock Exchange (NYSE) interested in media packages offered by OTC Tip Reporter can contact us today at 800-850-9305. Visit us online at otctipreporter.com and sign up for our newsletter. 

OTC Tip Reporter
Written by

OTC Tip Reporter

Top Emerging Growth Companies

Post a comment